Human Insulin Market by Drugs & Applications Human Insulin Market by Drugs & Applications

HEALTHCARE HUMAN INSULIN MARKET FORECASTS TO 2020 REPORT CODE BT 3981 HUMAN INSULIN MARKET - FORECASTS TO 2020 Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, Novorapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes) REPORT OVERVIEW 1.1 OBJECTIVES OF THE STUDY • To define, describe, and forecast the global human insulin market on the basis of product, human insulin drugs type, human insulin drugs brand, delivery device, and application • To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, opportunities, and challenges) • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for leading market players • To forecast the size of the market segments with respect to four main regions, namely, North America (U.S. and Canada), Europe (Germany, France, U.K., and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), and the Rest of the World • To strategically profile the key market players and comprehensively analyze their market shares and core competencies • To track and analyze competitive developments such as joint ventures; mergers and acquisitions; new product developments; and partnerships, agreements, and collaborations in the human insulin market [email protected] www.marketsandmarkets.com 1